Advanced search
Publication Cover
Food Additives & Contaminants: Part A Volume 34, 2017 - Issue 4: Special issue: Residues of veterinary medicines in food – recent developments in detection and determination. Guest Editors: Aldert Bergwerff, Leen van Ginkel and Saskia Sterk
Submit an article Journal homepage
214
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Investigation of the role of environmental contamination in the occurrence of residues of the veterinary drug phenylbutazone in cattle

Paul BarnesVeterinary Sciences Division, Agri-Food and Biosciences Institute, Belfast, UK
,
Terence L. FodeyVeterinary Sciences Division, Agri-Food and Biosciences Institute, Belfast, UK
,
Wesley G. SmythVeterinary Sciences Division, Agri-Food and Biosciences Institute, Belfast, UK
&
Steven R. H. CrooksVeterinary Sciences Division, Agri-Food and Biosciences Institute, Belfast, UKCorrespondence[email protected]
Pages 520-524 | Received 31 Aug 2016, Accepted 07 Dec 2016, Published online: 31 Jan 2017

References

  • Commission Decision 2002/657/EC. 2002. Implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off J Eur Eur Communities. L221:8–34.
  • [EFSA] European Food Safety Authority, 2015. 2015. Report for 2013 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. EFSA Supporting Publ. EN-723:69. Available from: www.efsa.europa.eu/publications.
  • [EFSA] European Food Safety Authority, 2016. 2016. Report for 2014 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. EFSA Supporting Publ. EN-923:70.
  • European Food Safety Authority. 2010. Report for 2008 on the results from the monitoring of veterinary medicinal product residues and other substances in food of animal origin in the Member States. EFSA J. 8:1559 55. Available from: www.efsa.europa.eu.
  • European Food Safety Authority. 2011. Report for 2009 on the results from the monitoring of veterinarymedicinal product residues and other substances in live animals and animal products. Supporting Publ. 158:70. Available from: www.efsa.europa.eu.
  • European Food Safety Authority. 2012. Report for 2010 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. Supporting Publ. 212:65. Available from: www.efsa.europa.eu.
  • European Food Safety Authority. 2013. Report for 2011 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. EFSA Supporting Publ. EN-363:65. Available from: www.efsa.europa.eu/publications.
  • European Food Safety Authority and European Medicines Agency. 2013. Joint statement of EFSA and EMA on the presence of residues of phenylbutazone in horse meat. EFSA 2013. 11:3190.
  • European Food Safety Authority, 2014. 2014. Report for 2012 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products. EFSA Supporting Publ. EN-540:65. Available from: www.efsa.europa.eu/publications.
  • European Medicines Agency. 1997. Committee for medicinal products for veterinary use: phenylbutazone, summary report. EMEA/MRL/297/97-Final October 1997. European Medicines Agency. Available from: www.emea.europa.eu
  • Fodey TL, Smyth WG, Barnes P, Traynor IM, Kennedy DG, Crooks SRH. 2015. Investigation into sources of contamination of cattle with phenylbutazone. Vet Rec. 176:74-76.
  • Lees P, Ayliffe T, Maitho TE, Taylor JBO. 1988. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral-administration. Res Vet Sci. 44:57–67.
  • Lees P, Toutain P-L. 2013. Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses. Vet J. 196:294–303.
  • Martin K, Andersson L, Stridsberg M, Wiese B, Appelgren L-E. 1984. Plasma-concentration, mammary excretion and side-effects of phenylbutazone after repeated oral-administration in healthy cows. J Vet Pharmacol Ther. 7:131–138.
  • National Office of Animal Health. 2015. Equipalazone 1 g Oral Powder: clinical particulars. Enfield: NOAH.
  • Tobin T, Chay S, Kamerling S, Woods WE, Weckman TJ, Blake JW, Lees P. 1986. Phenylbutazone in the horse: a review. J Vet Pharmacol Ther. 9:1–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.